Tracking superbugs from mother to baby: a chicago study

NCT ID NCT06148480

First seen Jul 01, 2026 · Last updated Jul 01, 2026

Summary

This study looks at how drug-resistant bacteria, specifically ESBL-producing E. coli, are passed from mothers to their newborns during vaginal birth or scheduled C-sections. Researchers will test stool samples from 200 healthy mothers and their babies at a Chicago hospital to see how common these bacteria are and how often they are transmitted. By comparing the bacteria's genes, they hope to find what makes some strains better at spreading, which could lead to future ways to prevent infection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could identify genetic targets to reduce the spread of drug-resistant bacteria from mother to baby.

What could go wrong

This is an observational study, not a treatment trial. It may not lead directly to new therapies, and findings may not apply to all populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTI-ANTIBIOTIC RESISTANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

escherichia coli infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Prentice Women's Hospital

    Chicago, Illinois, 60611, United States